Crystallization and preliminary diffraction studies of SFC‐1, a carbapenemase conferring antibiotic resistance

Publisher: John Wiley & Sons Inc

E-ISSN: 1744-3091|68|9|1124-1127

ISSN: 1744-3091

Source: Acta Crystallographica Section F, Vol.68, Iss.9, 2012-09, pp. : 1124-1127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

SFC‐1, a class A carbapenemase that confers antibiotic resistance, hydrolyzes the β‐lactam rings of β‐lactam antibiotics (carbapenems, cephalosporins, penicillins and aztreonam). SFC‐1 presents an enormous challenge to infection control, particularly in the eradication of Gram‐negative pathogens. As SFC‐1 exhibits a remarkably broad substrate range, including β‐lactams of all classes, the enzyme is a potential target for the development of antimicrobial agents against pathogens producing carbapenemases. In this study, SFC‐1 was cloned, overexpressed, purified and crystallized. The SFC‐1 crystal diffracted to 1.6 Å resolution and belonged to the orthorhombic space group P212121, with unit‐cell parameters a = 65.8, b = 68.3, c = 88.8 Å. Two molecules are present in the asymmetric unit, with a corresponding VM of 1.99 Å3 Da−1 and a solvent content of 38.1%.